-
Featured Authors
-
Archives
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Category Archives: Health
Latest From Health
When is the Evidence “Enough” to Make a Health Care Decision?
At any given time, work is taking place in hundreds of laboratories throughout the country to develop new and better ways of combating disease and protecting our health and well-being. As the results of this research becomes more widely known, how long does it take before this new information changes the actual practice of medicine in hospitals, clinics and physicians’ offices? According to the Institute of Medicine, it takes an average of 17 years for Read More >
The Michael J. Fox Foundation Launches $10 Million Edmond J. Safra Core Programs
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has committed up to $10 million to its next funding round for the Edmond J. Safra Core Programs for PD Research to prioritize research toward transformative treatments and a cure for Parkinson’s disease (PD). We invite qualified researchers to apply to the Edmond J. Safra Core Programs for PD Research: Rapid Response Innovation Awards: This program supports high-risk, high-reward projects with little-to-no existing preliminary data, but with potential to significantly Read More >
Biodefense Preparedness Key for National Public Health
Over the last decade, our nation has responded to deliberate biological attacks – the mailing of anthrax-laden letters – and severe naturally-occurring disease outbreaks including SARS and the 2009-H1N1 flu pandemic. As an industry, biotechnology can help improve our nation’s capacity to prepare and respond to natural disasters, bioterrorist attacks, and outbreaks of infectious disease. The Biomedical Advanced Research and Development Authority (BARDA) was established to support the advanced development and procurement of drugs, vaccines, Read More >
New BIO Survey on Effective FDA – Sponsor Communication During Drug Development
BIO is surveying members on their interactions with the FDA during the various stages of drug development prior to submitting an NDA/BLA. The survey can be accessed here. In an increasingly competitive and fiscally-constrained environment, it is more important than ever for all stakeholders to work together to promote effective R&D for innovative medicines. This initial survey is designed to assist in the implementation of the Prescription Drug User Fee Act (PDUFA V) program on Read More >
Ellmers’ Cancer Bill Marks 100 Co-Sponsors
Today, Congresswoman Ellmers announced that 100 bipartisan cosponsors have signed on to support her bill – The Cancer Patients Protection Act of 2013 (H.R. 1416). The bill aims to ‘protect cancer patients from the harmful effects of the misallocated sequestration cuts.’ The bill also protects patients suffering from other diseases too. In a statement from the Congresswoman, she points out that the focus of sequestration is to reduce spending, but treating patients in hospitals is Read More >
